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Abstract
The interaction of the dinucleotides d(ApG) and d(ApA) with [Pd(aa)CI2], where aa L- or D-
histidine or the methyl ester of L-histidine, and with [Pt(Met)CI2], where Met = L-methionine was
studied by 1H and 3C NMR and CD measurements. In the case of the L-histidine and L-
histidineOMe, the reaction with d(ApG) appeared to give the bifunctional adducts Pd(L-
Histidine)Nl(1)N7(2) and Pd(L-HisOMe)NI(1)N7(2), but the behavior with D-histidine suggested
the formation of the monofunctional adduct Pal(D-His)N7(2). The reaction of L-histidine with d(ApA)
seemed to form the bimetallic adduct (L-His)PdN7(1)N7(2)Pd(L-His). The Pt(ll)-L-methionine
complex in both reactions with d(ApG) and d(ApA) seemed to yield mainly adducts Pt(L-
Met)N7(1)N7(2) but the existence of adducts Pt(L-Met)NI(1)N7(2)cannot be ruled out.
Introduction
The mechanism of Pt(ll) and other transition metal complexes binding to DNA has been
widely studied in the last few years. This mechanism of action of antitumoral drugs is not completely
understood, although the interaction of these compounds with DNA appears to be important. It has
been interpreted as the formation of bidentate chelates with two N atoms from neighboring
guanine bases(). The best know compound in this class of substances is the classic cis-
PtCI2(NH3)2 discovered as an antitumor drug by Rosenberg several decades ago(2). Many authors
have studied the reaction of possible new antitumoral complexes with nucleotides or
oligonucleotides.
Hollis et al. (3) reported a new class of platinum antitumor agents: cis-[PtCl(NH3)2(N-het)]CI
(N-het is a heterocyclic amine like pyridine). Possible mechanisms of action of the new compounds,
that must be different from that of the bifunctional cis-Pt(NH3)2CI2.have been proposed for this
unusual new class of compounds. It has been suggested that the bifunctional active species could
be generated in vivo; another possible interaction of this compound could be monofunctional
binding to guanines of the DNA, with N-het acting as an intercalator.
Reedijk and al. (4) studied the reaction of a new antitumoral complex of Pt(ll), cis-
[PtCl(NH3)2(4-methylpyridine)]CI with the dinucleotide d(GpG) and they report the preference for
platinum binding at the N7,N7 in the dinucleotide. In another paper, the same authors(5) studied
the conformation of the Pt(en)-dinucleotides in relation to the Pt(NH3)2-dinucleotides by 1H NMR
and CD spectroscopy and they found only small differences in the spectra, suggesting the same
structure for both adducts. Several authors have concluded that binding occurs by the formation of
a bifunctional adduct by the N7 atoms of two neighboring guanine bases(6-8). Hydrogen bonding
plays an important role in the stabilization of this pGpG-N7,N7 adduct. The preference for the
guanine N7 could be related to at least two factors: 1) the influence of the 5’-phosphate and
guanine 06, both of which can form hydrogen bonds to the amine group, and 2) the nature of the
neighboring bases to this sequence(9-z). The influence of a 5’phosphate group on the reactivity of
the N7 of a guanine in the reaction with platinum complexes was discussed.
A study of the guanine-O6 methylation of d(GpG) described the reduction of reactivity of
the dinucleotide towards Pt(ll) complexes(13) and the influence of the hydrogen bonding on the
preference of binding to the guanine-N7.
The aim of our work is to study the nucleotide coordination sites and the possibility of
chelate formation between the [Pd(L-Histidine)CI2], [Pd(D-Histidine)CI2], [Pd(L-HistidineOMe)CI2],
[Pt(L-Methionine)CI2], and the d(ApG) and d(ApA) dinucleotides. The structures of the [Pt(L-
Methionine)CI2], .[Pt(L-Histidine)CI2], and [Pd(L-HistidineOMe)CI2], have been determined
all (14, 15) crystallographic y
Several studies have been carried out on the synthesis of Pd(ll) complexes analogues of
Pt(ll) anticancer drugs and their interaction with dinucleotides or other DNA components. It is
apparent that the interest in the use of the Pd(ll) complexes as kinetic models is now increasing (6-
20).
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Materials and Methods
The palladium complexes and the platinum compound were synthesized and recrystallized
following established procedures(14,15) using K2PdCI4 or K2PtCI4 (Johnson Matthey products) and
the appropriate amino acid. The identity of the Pd/Pt derivatives was determined by infrared
spectroscopy and elemental analysis. The deoxynucleotides sodium salts d(ApG) and d(ApA) were
obtained from Sigma Chemicals and used without further purification, pH was adjusted by addition
of DCI or NaOD solutions. Values of pH (hereafter denoted pH*) were not corrected for deuterium
isotope effects. All the reactions, between 2-3 mmolar2-3 d(ApG) and d(ApA) were carried out in a
nliz M 1 ste zeal N R tube n D20 pH 7 at room temperature and were followed by H NMR spectroscopy
in function of time. Pd/Pt complexes in a 1:1 molar ratio were used. The H NMR and 3C NMR
spectra were recorded with a Varian 300 MHz spectrometer. D20 was used as a solvent and TMS as
internal reference. The CD spectra were recorded at room temperature on a Jasco 700 instrument
from solutions in the same conditions using H20 pH 7 as solvent) and concentrations that studied
by NMR at final time considered for the formation of the adducts. Electrospray mass Spectra of the
mixtures prepared were obtained on a VG-QUATTRO, Fisons Instruments, at 80C in dry N2, using
MeOH/H20 (1:1) as eluent with a flux of 7mL.min4.
Results and Discussion
The reaction between Pd(ll) histidine complexes and the dinucleotides was carried out in
D20 in a NMR tube and studied by 1H NMR spectroscopy. The pH of the all solutions, in this case,
was monitored to 6.8-7.2.
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Figure 1. Aromatic proton zone (ppm) of H NMR spectra
of the reaction between d(ApG) and [Pd(L-His)CI2] over time.
The resonances at 8.17, 7.79, and 7.54 ppm in the spectrum of the free dinucleotide
d(ApG) can be assigned to the H8 Ap, H2 Ap, and H8 pG respectively(2). The H NMR spectra of
the aromatic protons, for the d(ApG) and for a 1:1 mixture of d(ApG) and [Pd(L-His)CI2] over time are
represented n Figure 1.
Addition of [Pd(L-His)CI2] produced upfield shifts of the signals corresponding to the H8 pG
and to the H2 Ap while the H8 Ap remained unchanged. All the signals split in the following hours
but after 23 days this splitting disappeared and the intensity of the signals corresponding to H8 Ap
and H8 pG showed a progressive decrease until complete disappearance. At the same time, the
pH* of the solution decreased from 7.2 at the beginning to 5.4. The Electrospray mass spectra of
the final solution confirmed that the proton/deuterium exchange for H8 has occurred gradually,
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probably induced by the presence of the Pd(ll) ion bound to the nearby N7. In contrast, this H/D
exchange of the aromatic protons did not occur for the dinucleotide alone in solution in the same
conditions. In the literature, several authors have shown that the exchange occurs when the metal
ion is bound to the N7 site(22), which is considered as an additional aid in assigning the resonance
or, spontaneously, in the case of alkaline solutions with pH*s above 9 and at 37 9C or higher(23). In
our case we have confirmed that pH* was always lower than 7.5 and decresed to ca. 5 over time and
we have worked at 25 -C.
In the spectrum corresponding to the reaction of the dinucleotide d(ApG) with [Pd(L-
HisOMe)CI2] represented in Figure 2, no shifts in the signals were observed but splitting of the H2
Ap and H8 pG was detected. This splitting disappeared later. The H8 pG signal showed a slight
decrease after two months. Four months later this signal remained with analogous intensity. The
rate of the proton/deuterium exchange was smaller than in the case of the complex with L-histidine.
The formation of the adduct may be a slow process due to the presence of the methyl group and
binding of the Pd(ll) to N7 may take a long time; as a consequence the induction of the exchange of
the proton/deuterium may also be slower.
In the case of the reaction between [Pd(D-His)CI2] and d(ApG), see Figure 3, the H8 pG
signal shifted upfield and the other two aromatic proton resonances did not move. Although the
three signals split in the first steps of the reaction, the splitting disappeared over time. 45 days later,
a decrease in the intensity of H8 Ap and H8 pG was observed. After three months, the behavior
was similar to that of the L-histidine complex. The formation of the adduct was again more difficult
than in the case of L-histidine, due now to its spatial configuration which is less suitable for the
configuration of the dinucleotide[24]. Finally, the process of proton/deuterium exchange was
likewise induced, and five months later, the signals had disappeared completely.
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Figure 2. Aromatic proton zone (ppm) of 1H NMR spectra
of the reaction between d(ApG) and [Pd(L-HisOMe)CI2] over time.
The spectrum of the dinucleotide d(ApA) exhibits two signals at 8.21 and 7.91 ppm that can
be assigned to the H8 Ap and pA respectively [25-26]. The H2 Ap and H2 pA appear at 7.96 and
7.80 ppm respectively. The Figure 4 shows the aromatic resonances as well as the signal
corresponding to the reaction of d(ApA) with [Pd(L-His)CI2] in function of time.
When the [Pd(L-His)CI2] is added a downfield shift in all the signals can be seen, but no split
is observed in any case, even after 20 days. At this moment both resonances corresponding to the
H8 Ap and pA decrease progressively and, simultaneously, a fall in pH and a shift of all the
resonances in the spectrum can be detected. After four months, the signals corresponding to the
H8 Ap and pA disappear like in the reaction with d(ApG). This indicates that the formation of the
adduct with the adenine dinucleotide is slower than in the case of the adenin-guanine
dinucleotide. However, it seems that in all cases the reaction evolves towards the formation of an
adduct with the Pd(ll) binding to N7, which induces the proton/deuterium exchange.
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Figure 3. Aromatic proton zone (ppm) of H NMR spectra
of the reaction between d(ApG) and [Pd(D-His)CI2] over time.
The reaction between the complex of L-methionine and the dinucleotides was carried out
in D20 in an NMR tube and studied byH and 3C NMR spectroscopy. Previously, a pH-variation of
the NMR signals for the nucleotides was carried out and the conditions suitable for the study were
chosen. The pH* was monitored in all the cases at 3.
We can see in Table 1 the results for the H NMR spectra for the two different Pt complex-
dinucleotides.
Table 1. The most characteristicH NMR chemical shifts (ppm) for d(ApA) and d(ApG) and their
platinated complexes with [Pt(L-Met)CI2].
d(ApA)
assignment d(ApA) (pH=3) [Pt(L-Met).d(ApA)]
H2(Ap) 7.73 8.17
H8(Ap) 7.86 8.19
H2(pA) 7.87 8.21
H8(pA) 8.15 8.37
(pH=3)
d(ApG)
assignment d(ApG) (pH=3) [Pt(L-Met)-d(ApG)]
H2(Ap) 7.60 8.10
H8(Ap) 7.96 8.25
H8(pG) 8.20 8.40
(pH=3)
The results of the 3C NMR study are shown in Table 2.
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Figure 4. Aromatic proton zone (ppm) of 1H NMR spectra of the reaction
between d(ApA) and [Pd(L-His)CI2] over time.
In the case of the d(ApA), the shiftings for the C8 of the two adenosine as well as the
shirtings of the protons H8 indicate that the binding of the Pt-complex would be through the N7
giving a Pt(L-Met)-d(ApA)N7(1 )N7(2) adduct. In the case of the dinucleotide d(ApG) the conclusion
=s, as in the first case, that the Pt complex could bind to the dinucleotide at the N7 positions, giv.ing
a Pt(L-Met)-d(ApG)N7(1)N7(2) adduct. However, the possibility of the presence of anotler
complex Pt(L-Met)-d(ApG)N1 (1)N7(2) cannot be ruled out(21).
Table 2. The most characteristic 13C NMR chemical shifts (pp_rn)for d(ApA) and d(ApG) and their
platinated complexes with [Pt(l.Met)CI2].
d(Aj)A)
asstgnment d(ApA) (pH:3) [Pt(L-Met)-d(ApA)]
C8(pA) 142.20 145.78
C8(Ap 142.83 147.68
C2(pA) 154.44 155.9(br)
C2(Ap) 154.70
(pH=3)
d(ApG)
assignment d(ApG) (pH=3) [Pt(L-Met)-d(ApG)]
C8/p.G 140:30 144.80
C8 Ap 142.20 147.80
C2/p_G
155.10 156.00
C2 Ap 155.20 157.10
(pH=3)
The behavior of the Pt(ll) complexes with methionine is different from that of Pd(ll) with
histidine. In this case all the bands remain throughout the experiment because the presence of
Pt(ll), at pH 3, does not induce the proton/deuterium exchange and, moreover, the modifications in
the position and forms of the signals are in agreement with the formation of the adducts by N7.
The instability of the Pt(ll)-Histidine complexes and the polymeric character of some of the
compounds isolated did not allow us to study their reactions with the dinucleotides. In the case of
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the [Pd(L-Met)CI2] we observed that the reaction with the dinucleotide is fast and the signals
corresponding to the H8 protons disappear immediately. This confirms that the presence of the
Pd(ll) ion in the neighborhood of N7 causes rapid proton/deuterium exchange. In the case of the
Pt(ll) derivatives no proton/deuterium exchange was observed at this low pH*.
A CD study of the solutions of the complexes of Pd(ll) with L, D- Histidine and the methyl
ester of L-Histidine gave complementary data which confirm the conclusions from the discussion
based on the NMR study. The CD spectra of the solutions with the products of the reactions of
d(ApG) and d(ApA) and the Pd(ll) complexes are shown in Figures 5 and 6.
The spectrum of free d(ApG) presents two negative effects at 270 and 230 nm and one
positive effect at 248 nm. In the cases of the reactions of d(ApG) with [Pd(L-His)CI2] and [Pd(L-
HisOMe)CI2] a change in the sign of the band at 230 nm is observed which now appears in the
adducts at 230 and 228 nm respectively, while no change is observed in the sign for the other
bands (268 and 265 nm and 245 and 248 nm respectively). The ellipticity of the positive bands at
245 and 248 nm also changes. Theses modifications indicate that a conformational change takes
place in relation to the free dinucleotide(23, 27). In contrast, in the CD spectrum of the reaction
mixture of d(ApG) with [Pd(D-His)CI2] there is no change of sign, but only a considerable variation in
the ellipticity of the band at 230 nm. Probably in this case the conformation of the adduct is the
same as in the free dinucleotide.
Figure 5. CD spectra of d(ApG) and the products of the reactions
between d(ApG) and [Pd(L-His)CI2], [Pd(L-HisOMe)CI2], and [Pd(D-His)CI2]
The conformational changes for [Pd(L-His)CI2] and [Pd(L-HisOMe)CI2] agree with the
formation of bifunctional adducts while the retention of the conformation in [Pd(D-His)CI2] suggests
that only monofunctional dinucleotide-Pd(ll) adducts are present.
Finally, in the spectrum of free d(ApA) there are three bands, two positive at 270 and 218
nm, and one negative at 250 nm(27). After reaction with [Pd(L-His)CI2] no changes in the sign of any
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of the bands are observed. There are only slight modifications in the ellipticity indicating interaction
with the Pd(ll) complex. The retention of the conformation of the free d(ApA) can again be
interpreted due to the presence of monofunctional adducts(25).
Figure 6. CD spectra of d(ApA) and the product of the reaction
between d(ApA) and [Pd(L-His)CI2]
The CD study of the Pt(ll)-methionine derivatives and the dinucleotides was not possible
due to the presence of two isomers in solution. The sulfur atom of the methionine becomes chiral
after binding to the metal ion and there are two possible stereoisomers in the adducts formed. It
was not possible to separate them, and the CD spectra are those of the mixture of isomers.
Conclusions
The CD and H NMR study of the reaction of the dinucleotide d(ApG) with [Pd(L-His)CI2]
suggests the formation of the bifunctional adduct Pd(L-His)NI(1)NT(2) with an anti-anti
conformation.
In the case of the reaction of the dinucleotide d(ApG) with [Pd(L-HisOMe)CI.] the formation
of the bifunctional adduct Pd(L-HisOMe)N1 (1)N7(2) is also observed. The conformation is also anti-
anti. The reaction is slower probably due to the presence of the methyl group.
In the reaction of the dinucleotide d(ApG) with [Pd(D-His)CI2] only the monofunctional
adduct Pd(D-His)N7(2) seems to be formed. The conformation is in this case anti-syn.
The CD and 1H NMR study of the reaction of the dinucleotide d(ApA)with [Pd(L-His)CI2]
agrees with the formation of bimetallic adducts with formulae (L-His)PdN7(1)N7(2)Pd(L-His). The
conformation in this case is also anti-syn.
The disappearance of H8 signals in some of the reactions over time indicates H exchange
with deuterium induced by the presence of the Pd(ll) atoms binding to the N7.
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The 1H NMR and 3C NMR study of the reaction of the dinucleotides d(ApG) and d(ApA)
with [Pt(L-Met)CI2] suggests the formation of the bifunctional adducts.
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